Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated 4 Květen 2021 News Human COVID-19 Vaccines EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15 3 Květen 2021 News Human COVID-19 Vaccines EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen 29 Duben 2021 News Human COVID-19 Medicines EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe 26 Duben 2021 News Human AstraZeneca’s COVID-19 vaccine: benefits and risks in context 23 Duben 2021 News Human COVID-19 Vaccines Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from BioNTech/Pfizer and Moderna 23 Duben 2021 News Human COVID-19 Vaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2021 23 Duben 2021 News Human Generic and hybrid medicines Medicines Referrals New treatment for rare autoimmune disease of nerve cells 23 Duben 2021 News Human Medicines EMA working on COVID-19 during closure on 27 April 2021 23 Duben 2021 News Corporate COVID-19 Clinical Trials Information System reaches major milestone towards go-live and application of the Clinical Trial Regulation 21 Duben 2021 News Human Clinical trials 1 … 62 63 64 65 66 Page 66 of 380 67 68 69 70 … 380
EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated 4 Květen 2021 News Human COVID-19 Vaccines
EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15 3 Květen 2021 News Human COVID-19 Vaccines
EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen 29 Duben 2021 News Human COVID-19 Medicines
EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe 26 Duben 2021 News Human
AstraZeneca’s COVID-19 vaccine: benefits and risks in context 23 Duben 2021 News Human COVID-19 Vaccines
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from BioNTech/Pfizer and Moderna 23 Duben 2021 News Human COVID-19 Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2021 23 Duben 2021 News Human Generic and hybrid medicines Medicines Referrals
Clinical Trials Information System reaches major milestone towards go-live and application of the Clinical Trial Regulation 21 Duben 2021 News Human Clinical trials